Hepatitis B | Clinical Medicine

Overview

Ninja Nerd's comprehensive lecture on Hepatitis B covers the virus's structure, including its enveloped nature and key viral proteins like HBsAg, HBcAg, and HBeAg. The presentation details transmission routes (blood, sexual, perinatal), the virus's life cycle within hepatocytes involving reverse transcription, and the immune response, including the role of CD8+ T cells and the formation of immune complexes leading to symptoms like serum sickness. It also addresses chronic infection, cirrhosis, hepatocellular carcinoma, acute liver failure, diagnostic serological panels (HBsAg, anti-HBc, anti-HBs), treatment with antivirals like entecavir and tenofovir, and prevention through vaccination.

Key takeaways

Hepatitis B virus (HBV) is an enveloped DNA virus transmitted via blood, sexual contact, and vertically; its replication involves reverse transcription.
The immune response, particularly CD8+ T cells, drives hepatocyte damage, leading to acute hepatitis, while failure to clear the virus results in chronic infection, cirrhosis, and hepatocellular carcinoma.
Diagnosis relies on a serological 'triple panel' (HBsAg, anti-HBc, anti-HBs) to differentiate acute, chronic, resolved, or immunized states.
Chronic HBV is managed with antivirals (entecavir, tenofovir) that inhibit viral DNA polymerase, reducing viral load and transmission risk.
Hepatitis D co-infection or super-infection significantly worsens HBV outcomes, increasing risks of cirrhosis and acute liver failure.
Vaccination is the primary prevention strategy, providing long-term immunity; immunoglobulin offers immediate protection in high-risk scenarios.

Chapters

0:08 Hepatitis B Virus Structure and Key Antigens

Hepatitis B virus (HBV) is an enveloped virus with a partial double-stranded DNA genome.
Key viral proteins include Hepatitis B surface antigen (HBsAg), Hepatitis B core antigen (HBcAg), and Hepatitis B envelope antigen (HBeAg).
HBsAg indicates infection, HBeAg indicates replication and infectivity, and HBcAg is not directly measured but its antibody (anti-HBc) is significant.

7:30 HBV Genome and DNA Polymerase

The genome is a partial double-stranded DNA molecule.
HBV possesses a DNA polymerase with reverse transcriptase abilities, crucial for its replication cycle.
This reverse transcriptase activity is a target for antiviral medications.

11:41 Antibodies Against HBV Antigens

Plasma cells produce antibodies against HBsAg, HBcAg, and HBeAg.
Anti-HBs antibodies are crucial for immunity and indicate resolution or vaccination.
Anti-HBc antibodies (IgM for acute, IgG for chronic/resolved) are important diagnostic markers.
Anti-HBe antibodies can indicate decreased replication.

17:26 Hepatitis D: The Dependent Virus

Hepatitis D virus (HDV) is a "defective" RNA virus that requires HBV for replication and infection.
Co-infection (simultaneous HBV and HDV) increases disease severity.
Super-infection (HDV infection in a chronically HBV-infected individual) significantly increases the risk of cirrhosis and acute liver failure.

24:16 Transmission Routes of Hepatitis B

HBV is transmitted through blood (IV drug use, needle sticks), sexual contact, and vertically from mother to child (perinatal transmission).
Horizontal transmission occurs between individuals, while vertical transmission is mother-to-newborn.
Perinatal transmission is a major risk factor for chronic infection.

27:21 HBV Entry into Hepatocytes

After entering the bloodstream, HBV travels to the liver, primarily via the hepatic artery.
The virus binds to hepatocytes via the Hepatitis B surface antigen (HBsAg), utilizing receptors like NTCP.
Entry occurs through receptor-mediated endocytosis, forming an endosome.

35:07 HBV Replication Cycle: DNA to mRNA

Inside the hepatocyte, the partial double-stranded DNA genome is repaired into covalently closed circular DNA (cccDNA).
cccDNA serves as a template for viral mRNA synthesis via RNA polymerase.
Viral mRNA is then translated by ribosomes to produce viral proteins, including DNA polymerase.

38:53 HBV Replication Cycle: Reverse Transcription and Assembly

The viral DNA polymerase performs reverse transcription, converting pre-genomic RNA back into partial double-stranded DNA.
This DNA, along with viral proteins (HBsAg, HBcAg, HBeAg, DNA polymerase), is assembled into new virions.
New virions are released from the hepatocyte via exocytosis, leading to viremia.

46:46 Pathogenesis: Immune Response and Cytokine Release

Hepatocyte damage in HBV infection is primarily mediated by the immune response, not viral lysis.
Infected hepatocytes release DAMPs and PAMPs, activating Kupffer cells (liver macrophages).
Activated Kupffer cells release cytokines (IL-1, IL-6, TNF-alpha), causing vasodilation and increased capillary permeability, contributing to hepatic edema and potentially hepatomegaly.

55:01 Prodromal Symptoms: Serum Sickness

Antigen-antibody complexes form due to high HBsAg levels and insufficient antibody response.
These immune complexes deposit in joints and skin, triggering a hypersensitivity reaction (serum sickness).
Symptoms include arthralgias (joint pain), urticarial rash, mild fever, fatigue, nausea, and vomiting.

1:02:31 Adaptive Immune Response: CD8+ T Cells

Viral antigens are presented on MHC class I molecules on infected hepatocytes.
CD8+ cytotoxic T lymphocytes (CTLs) recognize these viral antigens via their T cell receptors.
Activated CD8+ T cells release perforins and granzymes, inducing hepatocyte apoptosis (cell death).

1:10:45 Clinical Manifestations: Acute Hepatitis

Hepatocyte death releases intracellular molecules like AST and ALT, leading to elevated serum levels.
Intrahepatic cholestasis causes bilirubin and bile salt backup, leading to jaundice (icterus), dark urine, and clay-colored stools.
Pruritus can occur due to bile salt deposition.

1:19:00 Chronic Hepatitis B: Pathogenesis and Risk Factors

Chronic infection occurs when the immune system, particularly CD8+ T cells, fails to clear the virus.
Neonate transmission has the highest risk of chronicity due to immature immune systems.
Chronic infection leads to slow, persistent hepatocyte damage over years, often remaining asymptomatic.

1:25:01 Progression to Cirrhosis

Persistent hepatocyte damage stimulates hepatic stellate cells to produce collagen and fibrous tissue.
Fibrosis leads to nodular changes, decreased liver function, and portal hypertension.
Cirrhosis can manifest as jaundice, hypoalbuminemia (edema), coagulopathy, hyperestrogenism, ascites, varices, and splenomegaly.

1:30:57 Hepatocellular Carcinoma (HCC) Risk

HBV is oncogenic, stimulating proto-oncogenes and inhibiting tumor suppressor genes (e.g., p53).
Chronic inflammation and viral integration increase mutation risk, leading to HCC.
HCC is often asymptomatic; surveillance with ultrasound and AFP levels is crucial.

Summary, takeaways, and chapters were generated by AI from the video's transcript and may contain errors. The video belongs to its creator, Ninja Nerd.